Vanguard Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Vanguard Capital Management's RCUS Position: Q3 2026 in Review
Vanguard Capital Management increased its Arcus Biosciences (RCUS) stake by 1.1% in Q3 2026, buying an estimated $1.21M and bringing the position to 3,931,334 shares worth $102M. The position accounts for ﹤0.01% of the portfolio, ranked #1514.
Vanguard Capital Management first reported a position in RCUS in Q1 2026 and has held it in 3 quarters since. The position peaked at $120M in Q2 2026. 243 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Vanguard Capital Management held 3,931,334 shares of Arcus Biosciences worth $102M as of Q3 2026.
- Vanguard Capital Management bought 42,988 Arcus Biosciences shares in Q3 2026, an estimated $1.21M.
- Arcus Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1514 holding.
- Vanguard Capital Management first reported a position in Arcus Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Arcus Biosciences position peaked at $120M in Q2 2026.
- 243 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.